Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926005690?dgcid=rss_sd_all
Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926005690?dgcid=rss_sd_all
“Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200.” Blood Advances.
@article{article97578,
title = {Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926005690?dgcid=rss_sd_all}
}